Geneos Wealth Management’s Houlihan Lokey HLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.39M Sell
30,538
-2,978
-9% -$490K 0.1% 222
2025
Q4
$5.84M Sell
33,516
-412
-1% -$75.6K 0.14% 179
2025
Q3
$6.97M Buy
33,928
+498
+1% +$97.6K 0.18% 145
2025
Q2
$6.02M Sell
33,430
-22,101
-40% -$3.71M 0.15% 168
2025
Q1
$8.97M Buy
55,531
+37,748
+212% +$6.48M 0.13% 190
2024
Q4
$3.09M Buy
17,783
+492
+3% +$86.6K 0.11% 211
2024
Q3
$2.73M Buy
17,291
+655
+4% +$97.8K 0.1% 229
2024
Q2
$2.24M Buy
16,636
+569
+4% +$74.5K 0.1% 235
2024
Q1
$2.06M Buy
16,067
+648
+4% +$80.2K 0.09% 247
2023
Q4
$1.85M Sell
15,419
-204
-1% -$22.1K 0.09% 245
2023
Q3
$1.67M Buy
15,623
+68
+0.4% +$7.01K 0.09% 244
2023
Q2
$1.53M Buy
15,555
+899
+6% +$81.3K 0.08% 248
2023
Q1
$1.28M Sell
14,656
-3,273
-18% -$308K 0.08% 260
2022
Q4
$1.56M Buy
17,929
+1,029
+6% +$92.5K 0.09% 212
2022
Q3
$1.27M Buy
16,900
+616
+4% +$49.9K 0.09% 216
2022
Q2
$1.27M Buy
16,284
+686
+4% +$57.4K 0.06% 271
2022
Q1
$1.37M Buy
15,598
+2,660
+21% +$274K 0.06% 280
2021
Q4
$1.34M Buy
12,938
+1,006
+8% +$107K 0.05% 324
2021
Q3
$1.11M Buy
11,932
+816
+7% +$71.5K 0.04% 352
2021
Q2
$913K Sell
11,116
-4,199
-27% -$304K 0.04% 386
2021
Q1
$1.01M Sell
15,315
-604
-4% -$40.8K 0.03% 419
2020
Q4
$747K Buy
15,919
+5,020
+46% +$325K 0.03% 436
2020
Q3
$614K Buy
10,899
+1,700
+18% +$97.4K 0.03% 389
2020
Q2
$491K Buy
+9,199
New +$536K 0.03% 415

Other funds holding HLI

Geneos Wealth Management's HLI Position: Q1 2026 in Review

Geneos Wealth Management reduced its Houlihan Lokey (HLI) stake by 8.9% in Q1 2026, selling an estimated $490K and leaving 30,538 shares worth $4.39M. The position accounts for 0.1% of the portfolio, ranked #222.

Geneos Wealth Management first reported a position in HLI in Q2 2020 and has held it in 24 quarters since. The position peaked at $8.97M in Q1 2025. 544 funds tracked by Wall St. Rank hold HLI as of Q1 2026.

  • Geneos Wealth Management held 30,538 shares of Houlihan Lokey worth $4.39M as of Q1 2026.
  • Geneos Wealth Management sold 2,978 Houlihan Lokey shares in Q1 2026, an estimated $490K.
  • Houlihan Lokey made up 0.1% of Geneos Wealth Management's portfolio in Q1 2026, its #222 holding.
  • Geneos Wealth Management first reported a position in Houlihan Lokey in Q2 2020 and has held it in 24 quarters since.
  • Geneos Wealth Management's Houlihan Lokey position peaked at $8.97M in Q1 2025.
  • 544 funds tracked by Wall St. Rank held Houlihan Lokey as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.